Improving Cognition in Schizophrenia Using tDCS
ICDC
1 other identifier
interventional
37
1 country
1
Brief Summary
This study will examine the benefits of transcranial direct current stimulation (tDCS), a new tool that is being developed as a safe and non-invasive neurostimulation method, for improving neurocognitive and social cognitive functions in schizophrenia. This procedure is non-invasive and painless and it results in increase or decrease of spontaneous neuronal firing in the brain. Its safety and beneficial effect on cognition has been demonstrated in healthy individuals and several clinical populations. In this pilot study, the investigators will examine the effect of tDCS on cognitive functions in 40 individuals with schizophrenia. Each participant will arrive for three visits, with approximately one week between each visit. During the first visit, participants will be interviewed about their psychiatric symptoms, personal life experiences, and emotional well being by a specially-trained interviewer. On each of the three visits, participants will receive one of three stimulations: a type of tDCS designed to increase neuronal firing, an alternative form of tDCS designed to decrease neuronal firing, and a sham tDCS (stimulation with no current). Immediately following the stimulation, participants will be asked to complete measures of mental abilities, including tests presented on a computer screen and paper-and-pencil tests. During each visit, participants will also undergo a standard measure of brain activity (EEG) while listening to tones. The first visit will last approximately five hours, and the other two visits will last approximately four hours each. The project will take approximately two years to complete.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Oct 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
August 26, 2015
CompletedFirst Posted
Study publicly available on registry
September 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedResults Posted
Study results publicly available
March 7, 2018
CompletedMarch 7, 2018
February 1, 2018
2 years
August 26, 2015
November 5, 2017
February 6, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Change From Baseline in Cognition on MCCB
Summary score of the cognitive domains on the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB). Four nonsocial neurocognitive tasks were included: speed of processing, working memory, verbal memory, and reasoning/problem solving. Normed T-scores were calculated for each cognitive subdomain, as well as the cognitive composite score consisting of the average across the four subdomains. The T-scores have a mean of 50, with a difference of 10 points from the mean equaling one standard deviation. Higher T-scores are indicative of higher cognition.
baseline and 20 minutes
Change From Baseline in Managing Emotions on MSCEIT
Total score on the Managing Emotions component of Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) The test consists of 141 items and 8 ability subtests, which assess four components of emotional processing. In this study, only branches 1 and 4 were administered, focusing on the Managing Emotions component. The total score reflects mean performance across the branches. The scores were converted to normed T-scores that have a mean of 50, with a difference of 10 points from the mean equaling one standard deviation. Higher T-scores are indicative of better performance.
baseline and 20 minutes
Study Arms (3)
tDCS anodal stimulation
EXPERIMENTALanodal stimulation
tDCS cathodal stimulation
ACTIVE COMPARATORcathodal stimulation
Sham stimulation
SHAM COMPARATORSham stimulation. Termination of electrical stimulation following 30 seconds
Interventions
comparing anodal, cathodal, and sham tDCS
Eligibility Criteria
You may qualify if:
- Diagnostic and Statistical Manual of Mental Disorders (DSM)-V Diagnosis of Schizophrenia
- Must understand spoken English sufficiently to comprehend testing procedures
- Estimated premorbid intelligence quotient (IQ) \> 70 (based on reading ability)
- Ongoing care of a Psychiatrist, Psychologist, or other qualified mental health professional
You may not qualify if:
- Metal in cranium
- Cardiac lines/pacemaker
- Medication pump
- Increased intracranial pressure
- Lifetime history of serious head injury (LOC \> 1 hr.)
- Sedatives or Benzodiazepines within 12 hours of testing
- Clinically significant neurological disease (e.g., seizures)
- History of mental retardation or developmental disability
- Alcohol or substance dependence in the last 6 months
- Alcohol or substance abuse in the last 1 month
- Change in medication in past 6 weeks
- Change in in living situation in the last 2 months
- Inpatient hospitalization in past 3 months
- Participation in prior studies involving tDCS
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA Semel Institute for Neuroscience and Human Behavior
Los Angeles, California, 90095, United States
Related Publications (1)
Rassovsky Y, Dunn W, Wynn JK, Wu AD, Iacoboni M, Hellemann G, Green MF. Single transcranial direct current stimulation in schizophrenia: Randomized, cross-over study of neurocognition, social cognition, ERPs, and side effects. PLoS One. 2018 May 7;13(5):e0197023. doi: 10.1371/journal.pone.0197023. eCollection 2018.
PMID: 29734347DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
The present findings employed a single tDCS administration, which may be insufficient to attain potential therapeutic effects. These findings thus add to the growing body of evidence suggesting the need for basic dose-finding studies in tDCS.
Results Point of Contact
- Title
- Dr. Yuri Rassovsky
- Organization
- University of California, Los Angeles
Study Officials
- PRINCIPAL INVESTIGATOR
Yuri Rassovsky, PhD
University of California, Los Angeles
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Research Psychologist
Study Record Dates
First Submitted
August 26, 2015
First Posted
September 3, 2015
Study Start
October 1, 2014
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
March 7, 2018
Results First Posted
March 7, 2018
Record last verified: 2018-02